SCHEMBL136919

SCHEMBL136919

CCN(Cc1cc(C)ccc1Br)C(=O)NC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 6/20 0.35
MEN1 O00255 3/20 0.35
RECQL P46063 1/20 0.35
KCNH2 Q12809 1/20 0.35
F2R P25116 1/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138101 0.83 HPGD (0.43) HPGDALDH1A1MAPTTDP1LMNA
SCHEMBL150893 0.81 PTGDR2 (0.43) MAPT
SCHEMBL134740 0.80 ALDH1A1 (0.51) HPGDALDH1A1MAPTLMNAKDM4E
SCHEMBL136551 0.79 CYP1A2 (0.46) HPGDALDH1A1MAPTTDP1KDM4E
SCHEMBL16501844 0.77 SSTR4 (0.41) HPGDALDH1A1MAPTTDP1LMNA
SCHEMBL137513 0.77 HPGD (0.54) HPGDALDH1A1MAPTTDP1LMNA
SCHEMBL137437 0.77 PTGDR2 (0.53) HPGDALDH1A1LMNAKDM4EKMT2A
SCHEMBL137058 0.77 HIF1A (0.33) HPGDALDH1A1TDP1KDM4EKMT2A
SCHEMBL12893455 0.72 PTGDR2 (0.49) ALDH1A1LMNAFFAR4KMT2AMEN1
SCHEMBL136567 0.72 PTGS2 (0.40) ALDH1A1FFAR4KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158036-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS PANMIRA PHARMACEUTICALS, LLC (US) 2013-06-20 US disclosed
US-8362044-B2 N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors PANMIRA PHARMACEUTICALS, LLC (US) 2013-01-29 US disclosed
US-20120058123-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS PANMIRA PHARMACEUTICALS, LLC. (US) 2012-03-08 US disclosed
US-20110039852-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158036-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS PTGDR, PTGDR2, PTGER2 HPGD 27/4885ALDH1A1 2005/4885MAPT 4866/4885
US-20110039852-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS PTGDR, PTGDR2, PTGER2 HPGD 27/4885ALDH1A1 2005/4885MAPT 4866/4885
US-20120058123-A1 N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS PTGDR, PTGDR2, PTGER2 HPGD 27/4885ALDH1A1 2005/4885MAPT 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.